| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19K | -2.0% | +31.5% |
| Cost of Revenue | $15K | +2.7% | -31.8% |
| Gross Profit | $4K | -14.7% | +163.3% |
| R&D Expense | $302K | +11.7% | +54.3% |
| SG&A Expense | $901K | -20.1% | +4.7% |
| Operating Income | -$1.8M | -5.4% | -41.3% |
| Pre-tax Income | -$1.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.3M | -11.6% | +764.4% |
| Accounts Receivable | $32K | +53.0% | +88.9% |
| Current Assets | $11.9M | -11.4% | +527.5% |
| Total Assets | $13.2M | -10.5% | +314.1% |
| Current Liabilities | $700K | +24.0% | +3.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.5M | — | — |
| Capital Expenditures | $8K | — | — |
| Investing Cash Flow | -$162K | — | — |
| Financing Cash Flow | $16.6M | — | — |
| Free Cash Flow | -$5.5M | — | — |
| -6.6% |
| -24.9% |
| Income Tax | $0 | — | — |
| Net Income | -$1.7M | -6.6% | -24.9% |
| EPS (Basic) | -$2.93 | -6.5% | -1853.3% |
| EPS (Diluted) | -$2.93 | -6.5% | -1853.3% |
| $700K |
| +24.0% |
| +3.2% |
| Stockholders' Equity | $12.5M | -11.9% | +398.1% |